Strata's Q1 2026: Record Revenue, M&A, & Growth

Stratas Q1 2026 earnings report is a scorcher, with revenue surging 87% to $67.4M, beating expectations on both top and bottom lines. Logistics grew 32% to $47.6M, while the new Clinical side contributed $19.8M, up 12% from last quarter. They acquired Ohio Valley Perfusion for $1M and have a robust M&A pipeline. Strata expanded their fleet to 10 owned planes and opened new bases, now with 20 hubs nationwide. The transplant market is rebounding, with deceased donors improving sequentially. Stratas financials show gross profit doubling to $14.1M at a 21% margin, adjusted EBITDA at $6.4M, and positive free cash flow before plane purchases. They maintain full-year guidance of $260-$275M revenue and $29-$33M adjusted EBITDA, with Q2 revenue up low single digits and margins ticking higher. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bd5e86bb62c6a126